SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318154-19-000018
Filing Date
2019-05-01
Accepted
2019-04-30 18:37:54
Documents
84
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q amgn-2019331x10q.htm 10-Q 1674333
2 RULE 13A-14(A) CERTIFICATIONS amgn-ex31_2019331xq1.htm EX-31 23784
3 SECTION 1350 CERTIFICATIONS amgn-ex32_2019331xq1.htm EX-32 10899
  Complete submission text file 0000318154-19-000018.txt   9982844

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT amgn-20190331.xml EX-101.INS 2767051
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amgn-20190331.xsd EX-101.SCH 58091
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amgn-20190331_cal.xml EX-101.CAL 90967
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amgn-20190331_def.xml EX-101.DEF 307049
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amgn-20190331_lab.xml EX-101.LAB 714776
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amgn-20190331_pre.xml EX-101.PRE 450212
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37702 | Film No.: 19784109
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1